Patents Assigned to Purdue Pharmaceuticals, L.P.
-
Patent number: 9872836Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.Type: GrantFiled: February 4, 2016Date of Patent: January 23, 2018Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
-
Patent number: 9867783Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.Type: GrantFiled: March 4, 2015Date of Patent: January 16, 2018Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
-
Patent number: 9867784Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.Type: GrantFiled: February 9, 2016Date of Patent: January 16, 2018Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
-
Patent number: 9861582Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.Type: GrantFiled: February 4, 2016Date of Patent: January 9, 2018Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
-
Patent number: 9861583Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.Type: GrantFiled: November 17, 2016Date of Patent: January 9, 2018Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Curtis Wright, Benjamin Oshlack, Christopher Breder
-
Publication number: 20170354607Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: December 14, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170348240Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: August 22, 2017Publication date: December 7, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170348241Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: August 22, 2017Publication date: December 7, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319490Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319496Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319488Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319491Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319495Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319489Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319497Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319494Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319492Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319498Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Publication number: 20170319493Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.Type: ApplicationFiled: July 24, 2017Publication date: November 9, 2017Applicants: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P.Inventors: William H. MCKENNA, Richard O. MANNION, Edward P. O'DONNELL, Haiyong H. HUANG
-
Patent number: 9808453Abstract: Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid.Type: GrantFiled: December 19, 2016Date of Patent: November 7, 2017Assignees: Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P.Inventors: Benjamin Oshlack, Curtis Wright, Christopher Breder
